Bileaflet mitral valve prolapse and risk of ventricular dysrhythmias and death

Benjamin D. Nordhues, Konstantinos C. Siontis, Christopher G. Scott, Vuyisile T Nkomo, Michael John Ackerman, Samuel J Asirvatham, Peter Noseworthy

Research output: Contribution to journalArticle

18 Citations (Scopus)

Abstract

Dysrhythmias and Death in BiMVP Introduction Bileaflet mitral valve prolapse (BiMVP) is common among survivors of otherwise unexplained sudden cardiac death, but prognostic implications of BiMVP are unknown. This study evaluated whether patients with BiMVP are at higher risk for ventricular dysrhythmias, ICD placement, or death compared to controls with either single-leaflet mitral valve prolapse (SiMVP) or no mitral valve prolapse (MVP). Methods and Results This retrospective, matched cohort study included 18,786 patients who underwent echocardiography at Mayo Clinic between June 1990 and September 2014. The study included three cohorts: BiMVP, SiMVP, and controls without MVP. We assessed rates of ventricular dysrhythmias, ICD placement, and all-cause mortality between groups. BiMVP was associated with higher rates of ventricular tachycardia compared to SiMVP and controls (adjusted HR 1.48 [1.14-1.92], P = 0.003 and 1.40 [1.04-1.88], P = 0.026, respectively); however, there were no statistically significant differences in rates of ventricular fibrillation/cardiac arrest or ICD placement between groups. BiMVP was associated with a lower rate of all-cause mortality compared to SiMVP and controls (adjusted HR 0.86 [0.79-0.94], P = 0.0008, and 0.55 [0.50-0.60], P <0.0001, respectively). Conclusion Although BiMVP is associated with ventricular tachycardia, it is not associated with an increased risk of cardiac arrest/ventricular fibrillation or ICD implantation and is, paradoxically, associated with a better survival compared to SiMVP or matched controls. The findings suggest that, despite its association with ventricular tachycardia, BiMVP in the absence of other risk factors does not seem to portend a poor prognosis at the population level.

Original languageEnglish (US)
Pages (from-to)463-468
Number of pages6
JournalJournal of Cardiovascular Electrophysiology
Volume27
Issue number4
DOIs
StatePublished - Apr 1 2016

Fingerprint

Mitral Valve Prolapse
Ventricular Tachycardia
Ventricular Fibrillation
Heart Arrest
Mortality
Sudden Cardiac Death

Keywords

  • bileaflet mitral valve prolapse
  • implantable cardioverter-defibrillator
  • mitral valve prolapse
  • sudden cardiac death
  • ventricular fibrillation
  • ventricular tachycardia

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine
  • Physiology (medical)

Cite this

Bileaflet mitral valve prolapse and risk of ventricular dysrhythmias and death. / Nordhues, Benjamin D.; Siontis, Konstantinos C.; Scott, Christopher G.; Nkomo, Vuyisile T; Ackerman, Michael John; Asirvatham, Samuel J; Noseworthy, Peter.

In: Journal of Cardiovascular Electrophysiology, Vol. 27, No. 4, 01.04.2016, p. 463-468.

Research output: Contribution to journalArticle

@article{182a117069074980a893732c0222c1aa,
title = "Bileaflet mitral valve prolapse and risk of ventricular dysrhythmias and death",
abstract = "Dysrhythmias and Death in BiMVP Introduction Bileaflet mitral valve prolapse (BiMVP) is common among survivors of otherwise unexplained sudden cardiac death, but prognostic implications of BiMVP are unknown. This study evaluated whether patients with BiMVP are at higher risk for ventricular dysrhythmias, ICD placement, or death compared to controls with either single-leaflet mitral valve prolapse (SiMVP) or no mitral valve prolapse (MVP). Methods and Results This retrospective, matched cohort study included 18,786 patients who underwent echocardiography at Mayo Clinic between June 1990 and September 2014. The study included three cohorts: BiMVP, SiMVP, and controls without MVP. We assessed rates of ventricular dysrhythmias, ICD placement, and all-cause mortality between groups. BiMVP was associated with higher rates of ventricular tachycardia compared to SiMVP and controls (adjusted HR 1.48 [1.14-1.92], P = 0.003 and 1.40 [1.04-1.88], P = 0.026, respectively); however, there were no statistically significant differences in rates of ventricular fibrillation/cardiac arrest or ICD placement between groups. BiMVP was associated with a lower rate of all-cause mortality compared to SiMVP and controls (adjusted HR 0.86 [0.79-0.94], P = 0.0008, and 0.55 [0.50-0.60], P <0.0001, respectively). Conclusion Although BiMVP is associated with ventricular tachycardia, it is not associated with an increased risk of cardiac arrest/ventricular fibrillation or ICD implantation and is, paradoxically, associated with a better survival compared to SiMVP or matched controls. The findings suggest that, despite its association with ventricular tachycardia, BiMVP in the absence of other risk factors does not seem to portend a poor prognosis at the population level.",
keywords = "bileaflet mitral valve prolapse, implantable cardioverter-defibrillator, mitral valve prolapse, sudden cardiac death, ventricular fibrillation, ventricular tachycardia",
author = "Nordhues, {Benjamin D.} and Siontis, {Konstantinos C.} and Scott, {Christopher G.} and Nkomo, {Vuyisile T} and Ackerman, {Michael John} and Asirvatham, {Samuel J} and Peter Noseworthy",
year = "2016",
month = "4",
day = "1",
doi = "10.1111/jce.12914",
language = "English (US)",
volume = "27",
pages = "463--468",
journal = "Journal of Cardiovascular Electrophysiology",
issn = "1045-3873",
publisher = "Wiley-Blackwell",
number = "4",

}

TY - JOUR

T1 - Bileaflet mitral valve prolapse and risk of ventricular dysrhythmias and death

AU - Nordhues, Benjamin D.

AU - Siontis, Konstantinos C.

AU - Scott, Christopher G.

AU - Nkomo, Vuyisile T

AU - Ackerman, Michael John

AU - Asirvatham, Samuel J

AU - Noseworthy, Peter

PY - 2016/4/1

Y1 - 2016/4/1

N2 - Dysrhythmias and Death in BiMVP Introduction Bileaflet mitral valve prolapse (BiMVP) is common among survivors of otherwise unexplained sudden cardiac death, but prognostic implications of BiMVP are unknown. This study evaluated whether patients with BiMVP are at higher risk for ventricular dysrhythmias, ICD placement, or death compared to controls with either single-leaflet mitral valve prolapse (SiMVP) or no mitral valve prolapse (MVP). Methods and Results This retrospective, matched cohort study included 18,786 patients who underwent echocardiography at Mayo Clinic between June 1990 and September 2014. The study included three cohorts: BiMVP, SiMVP, and controls without MVP. We assessed rates of ventricular dysrhythmias, ICD placement, and all-cause mortality between groups. BiMVP was associated with higher rates of ventricular tachycardia compared to SiMVP and controls (adjusted HR 1.48 [1.14-1.92], P = 0.003 and 1.40 [1.04-1.88], P = 0.026, respectively); however, there were no statistically significant differences in rates of ventricular fibrillation/cardiac arrest or ICD placement between groups. BiMVP was associated with a lower rate of all-cause mortality compared to SiMVP and controls (adjusted HR 0.86 [0.79-0.94], P = 0.0008, and 0.55 [0.50-0.60], P <0.0001, respectively). Conclusion Although BiMVP is associated with ventricular tachycardia, it is not associated with an increased risk of cardiac arrest/ventricular fibrillation or ICD implantation and is, paradoxically, associated with a better survival compared to SiMVP or matched controls. The findings suggest that, despite its association with ventricular tachycardia, BiMVP in the absence of other risk factors does not seem to portend a poor prognosis at the population level.

AB - Dysrhythmias and Death in BiMVP Introduction Bileaflet mitral valve prolapse (BiMVP) is common among survivors of otherwise unexplained sudden cardiac death, but prognostic implications of BiMVP are unknown. This study evaluated whether patients with BiMVP are at higher risk for ventricular dysrhythmias, ICD placement, or death compared to controls with either single-leaflet mitral valve prolapse (SiMVP) or no mitral valve prolapse (MVP). Methods and Results This retrospective, matched cohort study included 18,786 patients who underwent echocardiography at Mayo Clinic between June 1990 and September 2014. The study included three cohorts: BiMVP, SiMVP, and controls without MVP. We assessed rates of ventricular dysrhythmias, ICD placement, and all-cause mortality between groups. BiMVP was associated with higher rates of ventricular tachycardia compared to SiMVP and controls (adjusted HR 1.48 [1.14-1.92], P = 0.003 and 1.40 [1.04-1.88], P = 0.026, respectively); however, there were no statistically significant differences in rates of ventricular fibrillation/cardiac arrest or ICD placement between groups. BiMVP was associated with a lower rate of all-cause mortality compared to SiMVP and controls (adjusted HR 0.86 [0.79-0.94], P = 0.0008, and 0.55 [0.50-0.60], P <0.0001, respectively). Conclusion Although BiMVP is associated with ventricular tachycardia, it is not associated with an increased risk of cardiac arrest/ventricular fibrillation or ICD implantation and is, paradoxically, associated with a better survival compared to SiMVP or matched controls. The findings suggest that, despite its association with ventricular tachycardia, BiMVP in the absence of other risk factors does not seem to portend a poor prognosis at the population level.

KW - bileaflet mitral valve prolapse

KW - implantable cardioverter-defibrillator

KW - mitral valve prolapse

KW - sudden cardiac death

KW - ventricular fibrillation

KW - ventricular tachycardia

UR - http://www.scopus.com/inward/record.url?scp=84962978221&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84962978221&partnerID=8YFLogxK

U2 - 10.1111/jce.12914

DO - 10.1111/jce.12914

M3 - Article

C2 - 26749260

AN - SCOPUS:84975780500

VL - 27

SP - 463

EP - 468

JO - Journal of Cardiovascular Electrophysiology

JF - Journal of Cardiovascular Electrophysiology

SN - 1045-3873

IS - 4

ER -